AI Helps Coronary CT Angiography and Accelerates the Development of Precision Medicine

This review was jointly published by Prof. Long-Jiang Zhang (Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University) and Prof. Christian Tesche (Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina and Department of Cardiology, Munich University Clinic, Ludwig-Maximilian-University).

With the continuous progress of science and technology, artificial intelligence (AI) has become an important driving force for a new round of scientific and technological revolution and industrial change. It aims to mimic human consciousness and thought processes, continuously learn and improve, and show a response close to or even beyond a real person. At present, machine learning, deep learning, and other AI technologies have been tried to be applied to intelligent diagnostic and decision making, image interpretation, accurate classification, and prognostication of cardiovascular diseases, which has led to broad application prospects and innovation potential.

As a safe and reliable non-invasive technique of choice for clinical screening of coronary heart disease, coronary CT angiography (CCTA) has been recommended by guidelines of the European and American societies as the use of Class 1A evidence for coronary artery disease. In recent years, the attempts of AI to run through the whole process of CCTA have expanded the application scope of CCTA. AI has shown great potential and advantages in many aspects of CCTA, including image quality optimization, fully automated calculation, quantitative and qualitative evaluation, etc.

This review systematically introduces the common AI techniques in the field of cardiovascular computed tomography (CT), summarizes the current research and application progress of AI in cardiovascular CT, and provides its future perspectives. We believe that the digital and intelligent management model of cardiovascular disease is expected to improve the management level and efficiency of diseases and provide patients with more accurate, safe, and appropriate diagnosis and treatment methods.

Peng-Peng Xu, Tong-Yuan Liu, Fan Zhou, Qian Chen, Jacob Rowe, Christian Tesche, Long-Jiang Zhang.
Artificial intelligence in coronary computed tomography angiography.
Medicine Plus, 2024. doi: 10.1016/j.medp.2023.100001

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...